GeneThera
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of GeneThera generated cash of $0, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2013 | -138.68K | -725 | 141.27K |
|---|---|---|---|
| 2014 | -124.94K | 0 | 123.70K |
| 2015 | -187.31K | -123.62K | 310.84K |
| 2016 | -169.24K | 0 | 169.24K |
| 2017 | -97.91K | -26.4K | 291.96K |
| 2018 | -462.61K | 0 | 300K |
| 2019 | 269 | 0 | 0 |
| 2020 | -5.30K | 0 | 0 |
| 2021 | -8.57K | 0 | 8.57K |
| 2022 | 0 | 0 | 0 |
GTHR Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 0 | 5.30K | 5.04K | 167.65K | -124.31K | 0 | 94 | 1.33K | 1.05K |
Operating activities | ||||||||||
Net income | 0 | -1.01M | -774.46K | -517.65K | -4.04M | -757.72K | -778.92K | -1.08M | -546.07K | -1.05M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 5.28K | 5.28K | 5.28K | 5.28K | 0 | 102.03K | 0 | 12.76K | 15.53K |
Stock-based compensation expense | 0 | 509.9K | 14.95K | 0 | 0 | 135K | 45K | 300.33K | 6 | 333.30K |
| Deferred income tax benefit | 0 | 509.9K | 14.95K | 0 | 0 | 135K | 45K | 300.33K | 6 | 333.30K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 12K | 0 | 0 | 22.49K | -7.16K | 0 | 0 |
Inventories | 0 | 0 | 0 | -12K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 487.73K | -9.98K | -28.97K | 645.20K | 531.40K | 284.48K | 598.51K | 0 | 0 |
Cash generated by operating activities | 0 | -8.57K | -5.30K | 269 | -462.61K | -97.91K | -169.24K | -187.31K | -124.94K | -138.68K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -26.4K | 0 | -110.62K | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | -26.4K | 0 | -13K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -725 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | -26.4K | 0 | -123.62K | 0 | -725 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 3.4K | 0 | 0 | 300K | 275K | 0 | 0 | 0 | 200 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -10.82K | 0 | 0 | 0 | 15K | -169.24K | 0 | 0 | 0 |
Cash used in financing activities | 0 | 8.57K | 0 | 0 | 300K | 291.96K | 169.24K | 310.84K | 123.70K | 141.27K |
Net Change In Cash | 0 | 0 | -5.30K | 269 | -162.61K | 291.96K | 0 | 310.84K | -1.23K | 276 |
Cash at end of period | 0 | 0 | 0 | 5.30K | 5.04K | 167.65K | 0 | 310.93K | 94 | 1.33K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |